Bacteriophages targeting adherent invasive <i>Escherichia coli</i> strains as a promising new treatment for Crohn's disease

Abstract

These findings demonstrate that bacteriophages are a new treatment option for targeting AIEC in CD patients and represent a strong basis for a clinical trial evaluation.